Dv0013 50628 — New Haven, Connecticut

Dv0013 50628 is a clinical research site located in New Haven, Connecticut, United States 06511.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Dv0013 50628 has participated in 1 clinical trials.

Therapeutic areas: Generalized Myasthenia Gravis.

Sponsors: UCB Biopharma SRL.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Dv0013 50628?

Dv0013 50628 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Dv0013 50628 conducted?

Dv0013 50628 has 1 clinical trials on record. Their work covers Generalized Myasthenia Gravis.

Is Dv0013 50628 accredited by Crixeo Health?

Dv0013 50628 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Dv0013 50628?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.